← All organizations

Biomedical Research Institute of New Mexico

Academic/Hospital

Also known as: Biomedical Research Institute of New Mexico | JoAnn Harnar

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 1, 2026

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 6 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

bempedoic acid

Other trials (1 own, 0 via acquisition)

rimabotulinumtoxinB

Indications

Studied for

Hypogonadism

Recent trials (7)

NCT07282821CollaboratorPhase 2Feb 1, 2026
NCT06333990CollaboratorPhase 3Jul 9, 2024
NCT05176626CollaboratorPhase 4Jun 30, 2022
NCT02367105CollaboratorPhase 3Feb 1, 2015
NCT01524705CollaboratorPhase 4Aug 1, 2012
NCT00945295Lead sponsorN/AJan 1, 2009
NCT00945295Sponsor investigatorN/AJan 1, 2009

Details

Last known activity: Feb 1, 2026